{"data":{"ModuleTitle":{"label":"Module Title","value":"Company Description"},"CompanyName":{"label":"Company Name","value":"Virpax Pharmaceuticals, Inc."},"Symbol":{"label":"Symbol","value":"VRPX"},"Address":{"label":"Address","value":"1055 WESTLAKES DRIVE,SUITE 300, BERWYN, Pennsylvania, 19312, United States"},"Phone":{"label":"Phone","value":"+1 610 727-4597"},"Industry":{"label":"Industry","value":"Biotechnology: Pharmaceutical Preparations"},"Sector":{"label":"Sector","value":"Health Care"},"Region":{"label":"Region","value":"North America"},"CompanyDescription":{"label":"Company Description","value":"Virpax Pharmaceuticals Inc is a preclinical stage biopharmaceutical company. The company is focused on developing pharmaceutical product candidates for pain management. Its product portfolio includes Topical metered-dose spray; Liposomal in Hydrogel encapsulation; and Enkephalin Intranasal spray."},"CompanyUrl":{"label":"Company Url","value":"https://www.virpaxpharma.com"},"KeyExecutives":{"label":"Key Executives","value":[{"name":"Sheila A. Mathias","title":"Chief Scientific Officer"}]}},"message":null,"status":{"rCode":200,"bCodeMessage":null,"developerMessage":null}}